| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that through its subsidiary, HUGE Biopharma Australia Pty Ltd., it entered into an agreement with Ingenu CRO Pty Ltd on February 19, 2024 to conduct "A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Assess the Safety and Efficacy of unbuzzd™ in Healthy Volunteers in an Induced State of Alcohol Intoxication (METAL-1 TRIAL)".
This trial is an important step to further verify that the effects of drinking unbuzzd™ helps a person sober up faster from the effects of alcohol. FSD Pharma's proprietary dietary supplement product is called unbuzzd™. unbuzzd™ is a fortified oral liquid formula that potentially enhances cognition, replenishes cofactors needed for alcohol metabolism, and may accelerate the rate of alcohol metabolism in the body allowing a person to sober up faster. Celly Nutrition Corp. ("Celly Nu"), led by beverage and marketing icons Gerry David, former CEO of Celsius, John Duffy former executive of Coca Cola and Kevin Harrington formerly on Shark Tank. Celly Nu is the holder of exclusive rights to FSD Pharma's technology for the recreational sale and use market. Separately FSD Pharma continues to develop a medical based product to accelerate the rate of alcohol metabolism for use in hospitals, medical centres and for front line workers.
"Our R&D team has worked tirelessly over the past year to accumulate science-based information to design the unbuzzd™ recreational alcohol use formulation. This clinical trial is an important next step to delivering science-based evidence to confirm what we believe we have discovered - a discovery which could potentially change the rate at which we metabolize alcohol in the body, or in simple terms sober up faster" said Mr. Zeeshan Saeed, CEO and co-founder of FSD Pharma.
